- CA$11.05m
- CA$29.19m
- CA$2.54m
Brief: Pharmacielo Says Received Global Good Agricultural Practices Certification For Colombian Medicinal-Cannabis Operations
Brief: Pharmacielo Receives Acceptance From TSX Venture Exchange Of Supply Agreement For Export Of 2018 Farm Bill Compliant CBD Isolate To U.S.
Australia's Creso Pharma hits record low on first day of trading after co's takeover terminated
Brief: Pharmacielo Announces Termination Of Scheme Implementation Agreement With Creso Pharma
Brief: Pharmacielo Provides Update On Proposed Acquisition Of Creso Pharma
Brief: PharmaCielo Announces Creso Pharma's Receipt Of Australian Court Approval To Convene Meeting Of Shareholders
Brief: Creso Pharma Updates On Status Of Its Proposed Acquisition By Pharmacielo Ltd
Brief: PharmaCielo Enters The U.S. With $3 Mln Q4 Sales Agreement And Completes Introductory Shipments To Multi-State Distributor General Extract
Brief: PharmaCielo Qtrly Loss Per Share $0.11
Brief: Creso Pharma Ltd Says Received Pharmacielo's First Commercial CBD Export From Colombia
Brief: Pharmacielo Expands Further Into Latin America
Brief: Pharmacielo First To Receive Colombian Government Export Approval For Commercial Sale Of CBD Isolate
Australian cannabis co Creso Pharma soars on Canada's PharmaCielo takeover offer
Brief: Pharmacielo Reports Qtrly Basic Loss Of $0.08 Per Common Share
Brief: Pharmacielo Doubles Its Portfolio Of Proprietary Cannabis Strains Approved For Colombia's Cultivar Registration
Brief: Pharmacielo Receives Approval For Cultivar Registration Of 10 Proprietary Cannabis Strains
Brief: Pharmacielo Establishes Joint Venture With Mino Labs To Bring Medicinal Cannabis Oil To Mexico